Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) price closed lower on Monday, September 13, dropping -15.95% below its previous close.
A look at the daily price movement shows that the last close reads $11.60, with intraday deals fluctuated between $9.50 and $11.46. Taking into account the 52-week price action we note that the stock hit a 52-week high of $36.00 and 52-week low of $3.70. The stock added 111.04% on its value in the past month.
Virpax Pharmaceuticals Inc., which has a market valuation of $64.94 million, is expected to release its quarterly earnings report May 18, 2021.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews.
The overview shows that VRPX’s price is at present -37.89% off the SMA20 and 6.50% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 41.47, with weekly volatility standing at 18.09%. The indicator jumps to 26.42% when calculated based on the past 30 days. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 2.97.
An analysis of the Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) stock in terms of its daily trading volume indicates that the 3-month average is 6.12 million.
Current records show that the company has 4.96M in outstanding shares. The insiders’ percentage holdings are 0.10% of outstanding shares while the percentage share held by institutions stands at 4.60%. But the 49.31% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.